Cognition Therapeutics Co-Founder and CSO Susan Catalano to Present at Sachs Neuroscience Innovation Forum Press Release, January 4th, 2018
Cognition Therapeutics’ Alzheimer’s Disease Candidate CT1812 Meets Phase 1b/2a Study Objectives: Well Tolerated with Positive Influence on Biomarkers of Synapse Recovery Press Release, November 4th, 2017
ALung Technologies Receives Expedited Access Pathway Designation from FDA for Hemolung Respiratory Assist System Press Release, November 4th, 2015
Cognition Therapeutics Completes Oversubscribed $12 Million Series B Financing Press Release, September 8th, 2015
Natural Infection Reduction: first reported use of a novel blood plasma-based product for treating open tibia fractures Press Release, July 31st, 2015
Pittsburgh researchers’ bone putty could revolutionize how broken bones mend Press Release, July 31st, 2015